[3] GOLDBERG A D,ALLIS C D,BERNSTEIN E.Epigenetics:a landscape takes shape[J].Cell,2007,128(4):635-638.
[4] MINUCCI S,PELICCI P G.Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer[J].Nat Rev Cancer，2006,6(1):38-51.
[5] 陈忠南,徐克前.表观遗传学药物FK228的药理作用及机制[J].国际病理科学与临床杂志,2008,28(4):297-301.
[6] 王生余,张旭辉.新型抗肿瘤药物组蛋白去乙酰化酶抑制剂[J].国际肿瘤杂志,2006,33(6):404-406.
[7] GREGORETTI I V,LEE Y M,GOODSON H V.Molecular evolution of the histone deacetylase family:functional implications of phylogenetic analysis[J].J Mol Biol,2004,338(1):17-31.
[8] BLANDER G,GUARENTE L.The Sir2 family of protein deacetylases[J].Annu Rev Biochem，2004,73(5):417-435.
[9] PFLUM M K，TONG J K，LANE W S，et al.Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation[J].J Biol Chem,2001,276(50):47733-47741.
[10] BOTTOMLEY M J，LO SURDO P，DI GIOVINE P，et al. Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural Zinc-binding domain[J].J Biol Chem,2008，283(39):26694-26704.
[11] TONG J J，LIU Jian-hong，BERTOS N R，et al. Identifi-cation of HDAC10,a novel class II human histone deacetylase containing a leucine-rich domain[J].Nuc Aci Res,2002,30(5):1114-1123.
[12] FRYE R A.Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins[J].Bioche Biophy Res Commun,2000,273(2):793-798.
[13] GAO Lin，CUETO M A，ASSELBERGS F，et al.Cloning and functional characterization of HDAC11,a novel member of the human histone deacetylase family[J].J Biol Chem,2002,277 (28):25748-25755.
[14] CRESS W D，SETO E.Histone deacetylases，transcriptional control，and cancer[J].J Cel Physiol,2000,184(1):1-16.
[15] 于亚平,王学文.组蛋白乙酰化酶和去乙酰化酶在细胞增生分化和肿瘤发生中的作用[J].医学研究生学报,2001,14(3):249-251.
[16] MINUCCI S，NERVI C，LO COCO F，et al.Histone deacetylases:a common molecular target for differentiation treatment myeloid leukemias.[J].Oncogene,2001,20(24):3110-3115.
[17] CUNLIFFE V T.Eloquent silence:developmental functions of Class I histone deacetylases[J].Curr Opin Genet Dev,2008,18(5):404-410.
[18] 夏昕晖,何莉,戴福宏,等.调控组蛋白乙酰化水平抑制膀胱癌细胞机理的研究进展[J].现代肿瘤医学,2008(16)5:871-873.
[19] WILSON A J，BYUN D S，NASSER S，et al.HDAC4 promotes growth of colon cancer cells via repression of p21[J].Mol Biol Cell,2008,19(10):4062-4075.
[20] WILSON A J，BYUN D S，POPOVA N，et al.Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer[J]. J Biol Chem,2006,281(19):13548-13558.
[21] RAMPALLI S，PAVITHRA L，BHATT A，et al. Tumor suppressor SMAR1 mediates cyclinD1 repression by recruitment of the SIN3/histone deacetylase 1 complex[J].Mol Cel Biol,2005,25(19):8415-8429.
百度搜索“77cn”或“免费范文网”即可找到本站免费阅读全部范文。收藏本站方便下次阅读，免费范文网，提供经典小说医药类组蛋白去乙酰化酶(HDACs)的研究进展(5)在线全文阅读。
